This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
We aimed to determine the risk of myocardial infarction (MI) and stroke after BSI. We included adults with community-acquired BSI between 2010 and 2020. MI and stroke were determined from International Classification of Disease Version 10 coded admissions. The risk was similarly elevated for stroke. to 15.32)).
Every year, the AHA reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors. In 2010, the AHA released a 2020 goal to improve the CV health of all Americans by 20%, while reducing CVD and stroke deaths by 20%. Excluding hypertension (CHD, HF, and stroke only), just 9.9%
BackgroundRacial and ethnic minority groups are at a higher stroke risk and have poor poststroke outcomes. Trials conducted in the United States, related to stroke and enrolling participants ≥18 years, were considered eligible. fold increase in reporting between 2010 and 2020. Overall, 60.1% White patients represented 65.0%
A BMJ study out of Denmark provided alarming new insights into atrial fibrillation’s impact on patients’ future cardiovascular health, while highlighting the need to improve post-AFib heart failure and stroke prevention. in 2000-2010 to 30.9% The researchers analyzed 2000-2022 data from 3.5M overall, increasing from 24.2% in 2011-2022.
Stroke, Volume 55, Issue 2 , Page 432-442, February 1, 2024. BACKGROUND:While most European Regions perform well in global comparisons, large discrepancies within stroke epidemiological parameters exist across Europe. CONCLUSIONS:EU-53 showed a 2% increase in incident strokes, while they remained stable in EU-28.
Research design and methods All patients with diabetes and CAD undergoing a coronary angiography between 2010 and 2021 according to the Swedish Angiography and Angioplasty Registry were included. Trend analyses for the years 2010–2019 revealed improved one-year MACE in patients with diabetes and CAD (year 2019 vs. 2010; 0.90; 0.81-1.00,
Stroke, Ahead of Print. There is growing interest in incorporating PROMs into clinical trials, but the extent that such measures are used in contemporary stroke trials is uncertain. Eligible studies were phase 2 or 3 trials that tested therapeutic interventions within 1 month of stroke onset.
Stroke, Volume 55, Issue 1 , Page 113-121, January 1, 2024. BACKGROUND:The extent to which genetic susceptibility modifies the associations between air pollutants and the risk of incident stroke is still unclear. These participants were followed up from the enrollment until the occurrence of stroke events or censoring of data.
Stroke, Volume 56, Issue Suppl_1 , Page A129-A129, February 1, 2025. Background:The most common cause of arterial ischemic stroke (AIS) in previously healthy children, focal cerebral arteriopathy (FCA) can progress rapidly over days with worsening brain injury. Study neuroradiologist (M.W.) and pediatric vascular neurologist (H.J.F.)
They were using data from the UK Biobank participants dated 2006 to 2010 and follow UP till the end of March 2021. There was also mild harmful effect on transition from healthy state to stroke.
ConclusionsIn routine practice, close to 30% of EVT treated stroke patients are over the age of 80 years. BackgroundOlder patients (80 years of age) were underrepresented in randomized trials of endovascular thrombectomy (EVT).
Stroke, Volume 56, Issue Suppl_1 , Page ADP16-ADP16, February 1, 2025. Introduction:The National Institutes of Health Stroke Scale (NIHSS) provides a clinical measure of stroke severity. We collected blood from each patient at hospital admission before administering any therapeutic intervention.
Stroke, Volume 55, Issue Suppl_1 , Page ATMP64-ATMP64, February 1, 2024. Introduction:Short-term dual antiplatelet therapy (DAPT) lowers the risk of early stroke recurrence after mild non-cardioembolic ischemic stroke (NCIS) and high-risk transient ischemic attack. in 2010 to 44.8% DAPT prescription increased from 24.2%
Stroke, Volume 55, Issue Suppl_1 , Page AWMP42-AWMP42, February 1, 2024. Background:Prior studies have shown that individuals who have an in-hospital stroke are less likely to receive thrombolysis. Few studies have investigated the trends of in-hospital strokes over time, and many large databases do not include in-hospital strokes.
Stroke, Volume 56, Issue Suppl_1 , Page ATP319-ATP319, February 1, 2025. Census tract stroke prevalence was estimated using 2021 CDC PLACES data. Stroke prevalence was 1.59% (95% CI:1.50-1.69) Stroke prevalence was also higher in tracts with declining investment (1.40%; 95% CI: 1.18-1.63%)
Stroke: Vascular and Interventional Neurology, Ahead of Print. The aim of this study is to describe trends in the utilization of RICS in MT in the United States in the last decade.METHODSWe conducted a serial crosssectional study using all primary acute ischemic stroke (AIS) admissions with MT in the 20102020 National Inpatient Sample.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue 6 , November 1, 2023. BackgroundIt is unclear whether all patient subgroups with acute ischemic stroke have benefited from advances in reperfusion therapy. Secular changes were assessed per 5‐year cohorts (2000–2005, 2006–2010, 2011–2015, 2016–2020). to 29.8%.
Stroke, Volume 55, Issue Suppl_1 , Page A43-A43, February 1, 2024. hours of ischemic stroke onset from 2003 to 2021. hours of ischemic stroke onset from 2003 to 2021. Thrombolysis rates and speed of treatment during TS phase I (2010-2013), II (2014-2018), and III (2019-2021) were compared with the pre-TS period (2003-2009).Results:Among
Stroke, Volume 56, Issue Suppl_1 , Page AWP154-AWP154, February 1, 2025. Objectives:Recurrent stroke results in higher disability and mortality but might be mitigated through interventions that improve medication adherence. per year after stroke (95%CI: 0.5 Neither FSRP nor stroke etiology were associated with recurrent stroke.
Stroke, Volume 56, Issue Suppl_1 , Page AHUP1-AHUP1, February 1, 2025. Introduction:Identification of modifiable drivers of the disparity between neighborhood socioeconomic status (nSES) and stroke outcomes remains elusive. We repeated the analyses stratified by stroke severity (NIHSS 5 or >5).Results:Among
Stroke, Volume 56, Issue Suppl_1 , Page ADP53-ADP53, February 1, 2025. Introduction:Identification of modifiable drivers of the disparity between neighborhood socioeconomic status (nSES) and stroke outcomes remains elusive. We repeated the analyses stratified by stroke severity (NIHSS 5 or >5).Results:Among
Stroke, Volume 55, Issue Suppl_1 , Page A96-A96, February 1, 2024. Introduction:While ischemic stroke (IS) in the young (18-55) is thought to have different etiologies than in older patients, a rise in vascular risk factors (VRFs) among young adults may translate to an IS risk profile similar to the older population. p <0.001).VRF
Stroke, Volume 56, Issue Suppl_1 , Page ATP45-ATP45, February 1, 2025. 58% of articles assessed ischemic and hemorrhagic stroke participants, and 9 studies only tested aphasia patients. Enhancements in these tools will expand access to testing and allow for increased identification of post-stroke cognitive impairment.
Stroke, Volume 55, Issue Suppl_1 , Page AWP256-AWP256, February 1, 2024. Background:Assessing the economic impact of stroke and the potential for prevention through policy and programs raises questions about progress and underscores the importance of state-level data for targeted public health resource allocation. P<0.05
Stroke, Volume 54, Issue 12 , Page 3054-3063, December 1, 2023. BACKGROUND:Patients with end-stage kidney disease undergoing dialysis are at significant risk of stroke. The primary outcome was incident acute ischemic stroke. Secondary outcomes included hemorrhagic stroke, acute coronary syndrome, and all-cause mortality.
Stroke, Volume 56, Issue Suppl_1 , Page A146-A146, February 1, 2025. Introduction:Patients with transient ischemic attack (TIA) and those with stroke mimics (MIM) are often difficult to distinguish in emergency room (ER) settings. While TIA patients are at an increased risk of stroke, MIM do not need stroke-related management.
Stroke, Volume 55, Issue Suppl_1 , Page ATMP82-ATMP82, February 1, 2024. Background:Prehospital stroke triage scores aim to identify LVO patients who benefit from direct transport to high-level stroke centers for EVT by bypassing primary stroke centers. The CSTAT and RACE scores were abstracted from the NIHSS.
Stroke, Volume 55, Issue Suppl_1 , Page A131-A131, February 1, 2024. The primary outcome was incident ischemic stroke. There were a total of 18 ischemic stroke events among those with LVI (6%) and 65 among those without LVI (3%). LV apical circumferential strain>-10% may be a novel and quantitative stroke risk factor.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionThe optimal management strategy for large vessel occlusion strokes (LVOS) from intracranial atherosclerotic disease (ICAD) remains debated. Endovascular intervention was defined as either angioplasty, stenting, or a combination of both.
Stroke, Volume 55, Issue Suppl_1 , Page AWP210-AWP210, February 1, 2024. Background:Optimal Blood pressure management after thrombectomy for acute ischemic stroke and its association with clinical outcomes remains unclear.
Stroke, Volume 55, Issue Suppl_1 , Page AWP192-AWP192, February 1, 2024. Introduction:Despite comparable outcomes for different frontline techniques in mechanical thrombectomy (MT) for acute ischemic stroke (AIS), there are sparse data regarding if and when to switch techniques if the first pass is unsuccessful.
Stroke, Volume 55, Issue Suppl_1 , Page AWMP84-AWMP84, February 1, 2024. Multivariate regression with generalized estimating equations, were used to determine whether premorbid-AD use was associated with an increased risk of ICH vs. ischemic strokeResults:A total of 219,558 stroke cases were identified (mean age 70.26±14.45;
Stroke, Ahead of Print. All participants were initially enrolled between 2006 and 2010 and were followed up until 2022. An air pollution score was calculated to assess joint exposure to 5 ambient air pollutants, namely particulate matter with diameters equal to or <2.5 µm, ranging from 2.5
Stroke, Volume 55, Issue Suppl_1 , Page ATP219-ATP219, February 1, 2024. Introduction:The outcomes of mechanical thrombectomy (MT) for patients with acute ischemic stroke (AIS) caused by medium vessel occlusions (MeVOs) in different vessels remains unknown. The primary outcome measure was a 90-day modified Rankin score (mRS) 0-2.
Literature has demonstrated that carotid artery stenting (CAS) poses greater risk of postoperative complications, particularly stroke, than carotid endarterectomy (CEA). Methods The National Inpatient Sample (NIS) was queried for patients undergoing CAS and CEA from 2010 to 2015. Primary outcome was in-hospital mortality.
Stroke, Volume 55, Issue Suppl_1 , Page AWP205-AWP205, February 1, 2024. The aim of this study is to develop and validate a stroke prediction tool for outcome in MT for AIS patients with low ASPECTS using data from an ongoing international multicenter registry, the Stroke Thrombectomy and Aneurysm Registry (STAR).Methods:236
Methods We enrolled patients from 2006 to 2010 using the Korean national insurance data. Methods We enrolled patients from 2006 to 2010 using the Korean national insurance data. Results Primary endpoint, a composite of MI, stroke and cardiac death rate was significantly higher in the PCI group than in the OMT group, 13.5/1000
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionRecombinant tissue plasminogen activator (rtPA) is the only approved treatment for acute ischemic stroke (AIS) patients, however, only a minuscule percentage of patients receive rtPA [1, 2].
Stroke, Volume 55, Issue Suppl_1 , Page ATP1-ATP1, February 1, 2024. Incidence rates were compared over time using linear regression after normalizing to 2010 census demographics. Background:There are conflicting data on temporal trends in subarachnoid hemorrhage (SAH) incidence and outcomes.
Between 2010 and 2012, participants completed a questionnaire, underwent a physical examination, and provided a fasting blood sample. We aimed to assess this.MethodsThis was a longitudinal analysis of data from the British Regional Heart Study, a prospective cohort study.
Stroke, Volume 55, Issue Suppl_1 , Page AWP204-AWP204, February 1, 2024. We aim to study the interplay between these factors in LCS and SCS patients.Methodology:Retrospective analysis of a comprehensive stroke center prospective database for patients with MCA-M1 or ICA-T occlusions who underwent MT between November 2010-March 2023.
Stroke, Volume 55, Issue Suppl_1 , Page AWP148-AWP148, February 1, 2024. Background:The recognition of in-hospital strokes (IHS) and their subsequent interventions remain challenging. IHS do not have guideline-based efficiency metrics established. Only 1 in 5 IHS receive treatment within 60 minutes of symptom recognition time (SRT).
Stroke, Ahead of Print. BACKGROUND:Although lower hemoglobin levels associate with worse intracerebral hemorrhage (ICH) outcomes, causal drivers for this relationship remain unclear. Patients with baseline hemoglobin measurements and serial computed tomography neuroimaging were included for analyses.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content